CN106636466A - Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) - Google Patents
Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) Download PDFInfo
- Publication number
- CN106636466A CN106636466A CN201611259032.9A CN201611259032A CN106636466A CN 106636466 A CN106636466 A CN 106636466A CN 201611259032 A CN201611259032 A CN 201611259032A CN 106636466 A CN106636466 A CN 106636466A
- Authority
- CN
- China
- Prior art keywords
- cccdna
- sample
- amplification
- positive
- rcdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA). The precise quantification method of the HBV cccDNA comprises steps as follows: the copy number of a sample is quantitatively controlled within 10,000 copes through nucleic acid; primers and probes of cccDNA and rcDNA are designed and detected with a double-gap method; digital PCR (polymerase chain reaction) amplification is performed; analysis parameters are adjusted in digital PCR instrument analysis software, 1/2-1/3 of the average fluorescence intensity of positive particles in positive control holes is set as a positive threshold, the to-be-detected sample is analyzed and the copy number of cccDNA in the sample is calculated using software of the digital PCR instrument, and false positive caused by non-specific amplification is eliminated. The method solves the false positive interference problem of double-gap method and the PCR method for rcDNA; compared with other digital PCR detection methods for cccDNA, the method has the advantages that specific DNA enzyme is not required to treat the sample, closed pipe operation is realized, the cross-pollution risk is reduced, and the operation process is simplified.
Description
Technical field
The present invention relates to a kind of method of DNA accurate quantifications, more particularly to a kind of hepatitis b virus covalence closed ring
The method of shape DNA (cccDNA) accurate quantification.
Background technology
Covalently closed circular DNA (covalently closed circular DNA) is referred to as cccDNA, is B-type hepatitis
Replicate and set up Infection Status after malicious host cells infected in the cell, the lax cyclic DNA (rcDNA) of virus enters nucleus,
Formed using host DNA polymerase and topological enzyme etc. " reparation ", structural integrity, superhelix double chain DNA molecule.CccDNA is deposited
It is the duplication " pond " for becoming hepatitis B virus in nucleus, it is still no at present to enter in nucleus, and can remove
The medicine of cccDNA, this is also one of the reason for easily recurring after existing antiviral treatment effect on driving birds is not good and treatment.
Detection by quantitative for cccDNA is hepatitis viruss detection difficult point, because there is various homologous hepatitis B virus DNAs point
Son is simultaneously deposited (cccDNA, rcDNA, ssDNA, the HBV DNA of integration), it is necessary to efficiently separate cccDNA and other kinds of virus
DNA。
At present the method for detection cccDNA includes intrusion method PCR (Wong, Hepatology, 2004:40), embedding and primer method
(Jun-Bin,J Virol Methods,2003:112), across rcDNA sonde method (He, Biochem Biophys Res
Commun 2002;295) etc..Intrusion method sensitivity is low, about 104copies/ml, and is easily subject to viral bootlegging process
The linearized double-stranded molecule interference of generation.Chimeric primers method except be similarly subjected to linearized double-stranded molecule disturb in addition to, in high abundance rcDNA
Can be disturbed by false positive in sample.Although will not be disturbed by linearized double-stranded molecule across the double breach quantitative PCR methods of rcDNA,
Can be because the incomplete extension products normal chain minus strand self annealing of rcDNA causes false positive to disturb in high abundance rcDNA samples.
Digital pcr carries out microdroplet process to sample, can produce 1 nanoliter of drop that is very uniform, repeating, each sample
Form 20,000 drops.Nucleic acid solution after Macrodilution is dispersed in the microreactor of chip or microdroplet, each reaction
The nucleic acid-templated number of device is less than or equal to 1.So after PCR cycle, there is the reactor of a nucleic acid templates
Fluorescence signal will be provided, the reactor without template is just without fluorescence signal.According to relative scale and the volume of reactor, just
The nucleic acid concentration of original solution can be extrapolated.Using digital pcr the thinking similar with normal PCR can be used to carry out cccDNA to determine
Amount (Di, Biotechnol Lett, 2015;Chinese Patent Application No. 201410755640.3,201510055540.4), it is former
Reason is similar with traditional quantitative PCR, using specific DNA enzymatic degradation rcDNA and single stranded DNA, then carries out routine with digital pcr
Quantitative work.
Problem quantitative for human liver cell cccDNA at present is mainly:Because the interference of other virus forms such as rcDNA
Cause cccDNA quantitatively inaccurate, the double breach methods often used on common quantitative PCR instruments can be subject to rcDNA non-specific amplifications
Interference cause false positive.
Therefore, it is necessary to develop a kind of new hepatitis b virus covalence closed cyclic DNA (cccDNA) accurate quantification
Method.
The content of the invention
It is an object of the invention to provide a kind of hepatitis b virus covalence closed cyclic DNA (cccDNA) accurate quantification
Method.
The method of hepatitis b virus covalence closed cyclic DNA (cccDNA) accurate quantification of the present invention, including with
Lower step:
A. by the copy number of nucleic acid quantification control sample within 10000 copies;
B. using the primer and probe of double breach method design detection cccDNA and rcDNA;
C. the amplification of digital P CR is carried out, using the cccDNA plasmids of concentration known as positive control;
D. after amplification terminates, analytical parameters are adjusted in digital pcr instrument analysis software, it is average with the positives microgranule of Positive control wells
The 1/2~1/3 of fluorescence intensity is set to positive threshold value, then carries software analysis sample to be tested by digital P CR instrument and calculates sample
CccDNA copy numbers in this, exclude the false positive caused by non-specific amplification.
According to the further feature of the method for the invention, in step A, using spectrophotometer measurement sample
OD260, OD280 numerical value, calculates the DNA concentration and purity in sample, and the concentration of sample is adjusted in 1000- using TE buffer
Between 10000/ microlitre.
According to the further feature of the method for the invention, in step B, amplification condition gathers with reference to used PCR
Synthase description, the design of amplification cycles number is between 15-25 circulations.
Each PCR reaction is distributed to the present invention principle of different individual drops using digital pcr, by it is traditional across
The double breach quantitative PCRs of rcDNA are referred in digital pcr, it is often more important that using the principle of end-point method fluoroscopic examination, utilized
CccDNA plasmids specimen determines detection threshold value as internal reference, excludes the double breach methods of rcDNA because too high incomplete extension of abundance produces
The false positive interference that thing normal chain minus strand self annealing is caused.The method of the invention solves the vacation sun of the double breach method PCR methods of rcDNA
Property interference problem, compared with other digital pcrs detection cccDNA, sample is processed without the need for specific DNA enzyme, realize and close
Pipe is operated, and reduces cross contamination risk and streamline operation.
Description of the drawings
Fig. 1 is carried out after digital pcr amplification as positive control template using cccDNA plasmids, by machine voluntarily interpretation threshold value
Testing result figure.
Fig. 2 is that, to detect that sample carries out digital pcr amplification, the threshold value arranged automatically using instrument carries out calculated inspection
Survey result figure.
Fig. 3 is to carry out digital pcr amplification with identical detection sample, and it is 3500 to adjust threshold value according to the result of Fig. 1, is carried out
Calculated testing result figure.
Specific embodiment
Across the double breach quantitative PCR methods of rcDNA be cccDNA detection methods popular at present, by rcDNA double-strands
The indentation, there both sides design primer of molecule and probe, make pcr amplification reaction terminate in indentation, there, so as to avoid rcDNA molecules
It is amplified and causes false positive, and cccDNA is because without breach, PCR can be normally carried out producing positive signal.But real reaction
In, always there are part rcDNA molecules its breach is repaired completely due to the reparation characteristic of PCR amplification enzymes, become cccDNA molecules
Form, so as to produce false positive results.
The method of hepatitis b virus covalence closed cyclic DNA accurate quantification of the present invention, comprises the following steps:
(1) using the OD260 of spectrophotometer measurement sample, OD280 numerical value calculates the DNA concentration and purity in sample, uses
The concentration of TE buffer adjustment sample controls the copy number of sample between 1000-10000/ microlitre from there through nucleic acid quantification
Within 10000 copies.
(2) using the primer and probe of double breach method design detection cccDNA and rcDNA;
The primer and probe of double breach method design cccDNA, sequence is as follows:
Forward primer:CTCCCCGTCTGTGCCTTCT(SEQ ID NO:1);
Reverse primer:GCCCCAAAGCCACCCAAG(SEQ ID NO:2);
Probe:FAM-CGTCGCATGGARACCACCGTGAACGCC-BHQ1.
(3) digital P CR (such as PCR instrument of Bio-Rad companies) is carried out, amplification condition is polymerized with reference to used PCR
Enzyme description, amplification cycles number is designed between 15-25 circulations, using the cccDNA plasmids of concentration known as positive control;
Digital pcr experiment condition:
95 degree of 10min;95 degree of 20s, 58 degree of 60s, 25 circulations.
(4) after amplification terminates, analytical parameters are adjusted in digital pcr instrument analysis software, it is positives micro- with Positive control wells
The 1/2~1/3 of grain average fluorescent strength is set to positive threshold value, then carries software analysis sample to be tested by digital P CR instrument
CccDNA copy numbers in sample are calculated, the false positive caused by non-specific amplification is excluded.
(5) interpretation of result:
Experiment every time is taken a hole and is expanded as positive control template using cccDNA plasmids.During analysis, by machine voluntarily first
The fluorescence threshold of interpretation Positive control wells, then arranges sample with the 1/2-1/3 of Positive control wells positive sample average fluorescent strength
The interpretation threshold value in this hole, then the cccDNA quantity of sample aperture is calculated by instrument.
Fig. 1 be expanded as positive control template using cccDNA plasmids after by machine voluntarily interpretation threshold value numeral
PCR testing result figures.Fig. 1 shows using cccDNA plasmids and expanded as positive control template, by machine voluntarily interpretation threshold value,
Differentiate negative, positive microdroplet.As shown in Figure 1, it is seen that the fluorescence intensity of positive microdroplet (top blue dot) be located at 6000-8000 it
Between, by positive microdroplet average fluorescent strength 1/2-1/3 as threshold value, therefore set 3500 as sample analyses positive threshold value.
The sample that this experiment is adopted actually does not contain cccDNA, containing only rcDNA.
Fig. 2 is to carry out digital pcr amplification with above-mentioned detection sample, and the threshold value arranged automatically using instrument is calculated
Testing result figure.As shown in Fig. 2 the threshold value arranged automatically using instrument is calculated, instrument sets threshold value as 1500 certainly, so as to
The sample is calculated containing 30 cccDNA copies, false positive occurs.False positive results herein should be rcDNA molecules by PCR enzymes
Extending the false cccDNA molecules of formation and being further used as template amplification is caused, and this is also false-positive in normal PCR test
Main source.
Fig. 3 is to carry out digital pcr amplification with identical detection sample, and it is 3500 to adjust threshold value according to the result of Fig. 1, is carried out
Calculated testing result figure.As shown in figure 3, it is 3500 to arrange threshold value according to the result of Fig. 1, instrument calculates the sample containing 0
Individual cccDNA copies, it is seen that the threshold value setting eliminates rcDNA false positive results from caused by extending.
Shown by above-mentioned experiment, method of the present invention efficiently solves the vacation sun of the double breach method PCR methods of rcDNA
Property interference problem, compared with other digital pcrs detection cccDNA, sample is processed without the need for specific DNA enzyme, realize and close
Pipe is operated, and reduces cross contamination risk and streamline operation.
Principle analysis:Digital pcr instrument is by the way that template molecule is distributed in 20000 microdroplets, when template molecule copy number
During significantly lower than microdroplet number, only comprising one or without template molecule in each microdroplet, single point is individually carried out in each microdroplet
The PCR reactions of subtemplate.The PCR of more than 1 is needed before being complete double-stranded DNA by PCR enzyme reparations in view of rcDNA molecules
Circulation is reacted, therefore is similarly the PCR reactions of unimolecule template, and amplification rate will at least be slower than normal cccDNA molecules mould
The time of one circulation of plate.The present invention is using the principle of end-point method fluoroscopic examination, by the use of cccDNA plasmid specimen as internal reference
Determine detection threshold value, exclude what the double breach methods of rcDNA were caused due to the too high incomplete extension products normal chain minus strand self annealing of demeanour
False positive is disturbed.
Claims (3)
1. a kind of method of hepatitis b virus covalence closed cyclic DNA accurate quantification, it is characterised in that comprise the following steps:
A. by the copy number of nucleic acid quantification control sample within 10000 copies;
B. using the primer and probe of double breach method design detection cccDNA and rcDNA;
C. the amplification of digital P CR is carried out, using the cccDNA plasmids of concentration known as positive control;
D. after amplification terminates, analytical parameters are adjusted in digital pcr instrument analysis software, it is average with the positives microgranule of Positive control wells
The 1/2~1/3 of fluorescence intensity is set to positive threshold value, then carries software analysis sample to be tested by digital P CR instrument and calculates sample
CccDNA copy numbers in this, exclude the false positive caused by non-specific amplification.
2. method according to claim 1, it is characterised in that:In step A, using spectrophotometer measurement sample
OD260, OD280 numerical value, calculates the DNA concentration and purity in sample, and the concentration of sample is adjusted in 1000- using TE buffer
Between 10000/ microlitre.
3. method according to claim 1, it is characterised in that:In step B, amplification condition refers to used PCR
Polymerase description, the design of amplification cycles number is between 15-25 circulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611259032.9A CN106636466A (en) | 2016-12-30 | 2016-12-30 | Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611259032.9A CN106636466A (en) | 2016-12-30 | 2016-12-30 | Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106636466A true CN106636466A (en) | 2017-05-10 |
Family
ID=58837497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611259032.9A Pending CN106636466A (en) | 2016-12-30 | 2016-12-30 | Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106636466A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107435083A (en) * | 2017-09-04 | 2017-12-05 | 上海市第十人民医院 | A kind of reliable clinical HBV DNA samples quantitative detecting method |
CN108285931A (en) * | 2018-03-30 | 2018-07-17 | 武汉大学 | A kind of the droplet type digital pcr method and kit of clinical detection HBV cccDNA |
CN109321679A (en) * | 2018-10-24 | 2019-02-12 | 北京大学 | Detect oligonucleotide composition, kit and the method and purposes of hepatitis B rcDNA and/or cccDNA |
CN112662745A (en) * | 2021-01-26 | 2021-04-16 | 重庆医科大学 | Method for quantitatively detecting hepatitis B virus covalent closed circular DNA by using digital PCR |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101967522A (en) * | 2009-07-27 | 2011-02-09 | 北京索奥生物医药科技有限公司 | Method for performing two-color fluorescence polymerase chain reaction (PCR) detection on hepatitis B virus covalently closed circular (ccc) DNA, and application of kit |
CN104388598A (en) * | 2014-12-11 | 2015-03-04 | 上海五色石医学研究有限公司 | Digital PCR quantitative detecting kit for HBV (hepatitis B virus) cccDNA and application of digital PCR quantitative detecting kit for HBV cccDNA |
CN104450963A (en) * | 2014-12-08 | 2015-03-25 | 上海五色石医学研究有限公司 | HBV DNA digital PCR quantitative detection kit and application thereof |
CN104630386A (en) * | 2015-02-03 | 2015-05-20 | 重庆医科大学附属第二医院 | Qualitative and absolute quantification kit for detecting hepatitis B virus cccDNA |
WO2016107833A1 (en) * | 2014-12-31 | 2016-07-07 | F. Hoffmann-La Roche Ag | A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr |
-
2016
- 2016-12-30 CN CN201611259032.9A patent/CN106636466A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101967522A (en) * | 2009-07-27 | 2011-02-09 | 北京索奥生物医药科技有限公司 | Method for performing two-color fluorescence polymerase chain reaction (PCR) detection on hepatitis B virus covalently closed circular (ccc) DNA, and application of kit |
CN104450963A (en) * | 2014-12-08 | 2015-03-25 | 上海五色石医学研究有限公司 | HBV DNA digital PCR quantitative detection kit and application thereof |
CN104388598A (en) * | 2014-12-11 | 2015-03-04 | 上海五色石医学研究有限公司 | Digital PCR quantitative detecting kit for HBV (hepatitis B virus) cccDNA and application of digital PCR quantitative detecting kit for HBV cccDNA |
WO2016107833A1 (en) * | 2014-12-31 | 2016-07-07 | F. Hoffmann-La Roche Ag | A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr |
CN104630386A (en) * | 2015-02-03 | 2015-05-20 | 重庆医科大学附属第二医院 | Qualitative and absolute quantification kit for detecting hepatitis B virus cccDNA |
Non-Patent Citations (7)
Title |
---|
HUI TANG等: "Comparison of droplet digital PCR to real-time PCR for quantification of hepatitis B virus DNA", 《BIOSCIENCE,BIOTECHNOLOGY,AND BIOCHEMISTRY》 * |
LAURE BOIZEAU等: "Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma?", 《JOURNAL OF CLINICAL MICROBIOLOGY》 * |
吕宜民: "《肝病诊疗经验 肝病临症》", 31 May 2014, 第二军医大学出版社 * |
李进等: "乙型肝炎病毒cccDNA的临床检测研究进展", 《胃肠病学和肝病学杂志》 * |
梁蔚芳等: "Ad-1.2乙型肝炎病毒感染HepG2细胞后HBV cccDNA的动态分析", 《南方医科大学学报》 * |
田志刚等: "《肝脏疾病的前沿研究"》", 31 August 2012, 中国协和医科大学出版社 * |
骆抗先等: "病毒性肝炎的病原学", 《广东医学》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107435083A (en) * | 2017-09-04 | 2017-12-05 | 上海市第十人民医院 | A kind of reliable clinical HBV DNA samples quantitative detecting method |
CN108285931A (en) * | 2018-03-30 | 2018-07-17 | 武汉大学 | A kind of the droplet type digital pcr method and kit of clinical detection HBV cccDNA |
CN109321679A (en) * | 2018-10-24 | 2019-02-12 | 北京大学 | Detect oligonucleotide composition, kit and the method and purposes of hepatitis B rcDNA and/or cccDNA |
CN112662745A (en) * | 2021-01-26 | 2021-04-16 | 重庆医科大学 | Method for quantitatively detecting hepatitis B virus covalent closed circular DNA by using digital PCR |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106636466A (en) | Precise quantification method of HBV (hepatitis B virus) cccDNA (covalent closed circular DNA) | |
CN107988428A (en) | Shrimp irido virus(SIV)RAA constant temperature fluorescence detection method and reagent | |
US11104948B2 (en) | NGS systems control and methods involving the same | |
CN105861641A (en) | Primer, kit and method for detecting CHO cell DNA residues | |
CN109457050A (en) | Detect primer, probe, kit and the detection method of hbv nucleic acid | |
CN111334608A (en) | Dual-fluorescence freeze-drying microchip, kit and method for detecting novel coronavirus 2019-nCoV | |
JP4535310B2 (en) | Real-time nucleic acid amplification multiple test analysis method | |
JP5810078B2 (en) | Nucleic acid quantification method | |
JP5744038B2 (en) | Analysis tool for amplification reaction | |
CN110747261A (en) | Specific primer, detection method and application of tetracycline antibiotic resistance gene tetX | |
CN101397592A (en) | Biological article for detecting hepatitis b virus covalence closed DNA and use thereof | |
CN109457052A (en) | Detect primer, probe, kit and the detection method of human immunodeficiency virus nucleic acid | |
CN107287347B (en) | Real-time fluorescence reverse transcription PCR (polymerase chain reaction) detection primer, probe, detection kit and detection method for hepatitis E virus | |
Dahlhausen | Future veterinary diagnostics | |
CN106755392B (en) | qPCR (quantitative polymerase chain reaction) method for rapidly and quantitatively detecting coelomacter in algae culture | |
CN110734965A (en) | Method and device for quickly obtaining PCR (polymerase chain reaction) result of POCT (point of care testing) | |
CN111575403A (en) | High-throughput digital PCR kit for detecting RNA virus nucleic acid and detection method | |
CN109468370A (en) | Method for rapidly detecting hereditary skin glycosylation capacity gene | |
CN116732209B (en) | Kit and method for simultaneously detecting drug resistance genes ISCR2 and FLOR based on digital PCR technology | |
CN110592271A (en) | RAA constant temperature fluorescence detection method and reagent for Infectious Hematopoietic Necrosis Virus (IHNV) | |
CN106939335A (en) | The method that acute-on-chronic liver failure controls gene is resisted in a kind of detection human serum | |
CN110747260A (en) | Specific primer, detection method and application of β -lactam antibiotic resistance gene blaTEM | |
CN106755393B (en) | qPCR (quantitative polymerase chain reaction) method for rapidly and quantitatively detecting Brachionus brachialis in algae culture | |
Agrawal et al. | TaqMan low-density arrays for simultaneous detection of multiple pathogens | |
Malewski et al. | RT-PCR technique and its applications. State-of the-art |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170510 |